Developer docs
API playgroundTry for free, no card

Search company profiles

Fapon

Full company profile

uuid004csh3

Namestring
Fapon
Legal namestring
Fapon Biotech Inc.
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Fapon Biotech is a privately held Chinese in vitro diagnostics (IVD) company founded in 2001 and headquartered in Dongguan, Guangdong. The company operates a vertically integrated 'one-stop IVD total solution' model spanning three product lines: core raw materials (antigens, antibodies, diagnostic enzymes, blockers, and calibrators), customized reagent development services, and open-system instruments (notably the Shine i-Series CLIA analyzers, the Ideal 30 molecular diagnostic system, and immunofluorescence analyzers). Technology coverage spans chemiluminescence immunoassay, ELISA, rapid test, molecular diagnostics (qPCR, NGS, LAMP), and clinical chemistry. The company serves IVD reagent manufacturers, clinical laboratories, and emerging-market IVD companies across 70+ countries via 2,500+ partners, using direct field sales, industry trade shows, and channel partnerships including joint ventures in Indonesia.

Fapon generates revenue through three streams: IVD raw materials sales to global IVD manufacturers as the primary revenue base, customized reagent services for assay development, and open-system instrument sales. Its economic model is built on an ecosystem approach — placing open-architecture analyzers (5,000+ globally) that allow partners to develop proprietary reagents, creating switching costs and recurring consumables demand. The company has supplied raw materials for 10+ billion COVID-19 tests and 200+ million malaria tests annually, supporting scale-based cost advantages. Pricing is negotiated on a B2B basis with multi-year contracts; no public pricing is disclosed.

The business is anchored by 1,200+ patent applications (450+ granted), 40% R&D headcount, and emerging scientific partnerships including Stanford Healthcare Innovation Lab and circRNA platform collaborations. The company operates a US R&D subsidiary in Lexington, MA (opened November 2023), and has pursued strategic partnerships with Roche Diagnostics China, Halodoc, Kalbe Farma, and Bio Farma to expand into new geographies. AI is used in biomarker discovery and bio-molecule design, though it functions as an internal R&D accelerator rather than a customer-facing product.

Short descriptiontext

Fapon Biotech is a Chinese IVD company founded in 2001 that provides a vertically integrated one-stop solution spanning raw materials, reagent services, and open-system instruments, serving 2,500+ IVD manufacturers and laboratories across 70+ countries through direct sales and channel partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDongguan, China
HQ citystring
Dongguan
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVD raw materials, chemiluminescence immunoassay, molecular diagnostics, diagnostic reagent services, open-system analyzers
Industry3 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
In Vitro Diagnostics (IVD) Raw Materials and Instruments
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1IVD Raw Materials Sales
TypeHardware Sales
Description

Sale of core IVD raw materials including antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers, and calibrators for CLIA, ELISA, rapid test, clinical chemistry, and molecular diagnostics platforms. This is Fapon's primary revenue stream, serving as a fundamental upstream supplier to IVD reagent manufacturers worldwide.

en.faponbiotech.com
2IVD Reagent Services
TypeProfessional Services
Description

Customized reagent development and manufacturing services for CLIA, high-throughput sequencing, quantitative fluorescence PCR (qPCR), and fluorescence-based lateral flow immunoassay. Provides semi-finished and finished bulk reagent solutions to IVD manufacturers.

en.faponbiotech.com
3Open-System Instruments
TypeHardware Sales
Description

Sale of open-architecture diagnostic instruments including the Shine i-Series chemiluminescence analyzers (i1000, i2000, i3000, i6000, i8000/9000, mT8000), Ideal 30 molecular diagnostic system, WS-Mi immunofluorescence analyzers, and Nous 30V veterinary analyzer. Instruments are sold to IVD manufacturers and laboratories.

en.faponbiotech.com
4Licensing (PSP Biomarker)
TypeLicensing Royalties
Description

Exclusive license from LASCCO SA and Abionic SA to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. Fapon develops, manufactures, and commercializes PSP raw materials and CLIA-based reagent solutions, generating revenue through product sales in the licensed territory.

en.faponbiotech.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1B2B raw materials and reagent services — pricing not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

As a B2B IVD raw materials and reagent services company, Fapon does not publicly disclose pricing. Customers contact sales for quotes on antigens, antibodies, enzymes, instruments, and reagent services.

en.faponbiotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Fapon Biotech is a global IVD upstream supplier providing a vertically integrated one-stop solution comprising (1) core raw materials — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators for CLIA, ELISA, rapid test, clinical chemistry and molecular diagnostics; (2) customized reagent development services for CLIA, NGS, qPCR and fluorescence lateral flow assays; and (3) open-system diagnostic instruments including the Shine i-Series chemiluminescence analyzers, Ideal/Nous molecular diagnostic systems, and WS-series immunofluorescence analyzers. The portfolio serves IVD reagent manufacturers, clinical laboratories, and emerging-market diagnostics companies across 70+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • hs-cTnI assay correlation (R²) reaches 0.9928 in AE-based CLIA within linear range (297 samples) and 0.9362 at concentrations < 0.1 ng/mL (141 samples)
+9 more records
Product overview1 text field

Fapon is a leading global provider of IVD total solutions comprising three interconnected product lines: IVD raw materials (antigens, antibodies, diagnostic enzymes, and blockers), IVD reagent services (customized development for CLIA, NGS, qPCR, and fluorescence-based assays), and open-system instruments (Shine i-series chemiluminescence analyzers ranging from i1000 to mT8000, Ideal and Nous molecular diagnostic systems, and WS immunofluorescence analyzers). The company also offers specialized reagent solutions for specific disease areas including infectious diseases (HIV, malaria, mpox), cardiac markers (hs-cTnI), Alzheimer's disease biomarkers, and vitamin D testing. The portfolio is unified through an ecosystem approach where raw materials feed into reagent services which run on open instruments, enabling partners to develop complete diagnostic solutions.

Product and service29 records
1IVD Raw Materials
CategoryIVD Raw Materials
Description

Core raw materials for in vitro diagnostics — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators — supplied to IVD reagent manufacturers across CLIA, ELISA, rapid test, clinical chemistry, and molecular diagnostics platforms. Over 1,300 product offerings across the line.

2IVD Reagent Services
CategoryIVD Reagent Services
Description

Customized reagent development and manufacturing services for CLIA, high-throughput sequencing (NGS), quantitative fluorescence PCR (qPCR), and fluorescence-based lateral flow immunoassay (FIA) applications. Delivers semi-finished and finished bulk reagent solutions to IVD manufacturers.

3Open-System Diagnostic Instruments
CategoryDiagnostic Instruments
Description

Open instrument platforms — chemiluminescence, molecular POCT, fluorescence immunochromatography, and high-throughput gene sequencing analyzers — sold to IVD manufacturers and laboratories. Enables partners to develop and run proprietary reagents on Fapon analyzers.

4Shine i8000/9000 Fully Automatic Chemiluminescence Immunoassay Analyzer
CategoryDiagnostic Instruments
Description

High-speed fully automatic chemiluminescence immunoassay analyzer with detection speed of 900 tests/hour, designed for mid- and high-volume laboratories. Compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.

5Shine i6000 Fully Automatic Chemiluminescence Immunoassay Analyzer
CategoryDiagnostic Instruments
Description

Automatic chemiluminescence immunoassay analyzer designed for medium-throughput laboratories, compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.

6Shine i3000 Fully Automatic Chemiluminescence Immunoassay Analyzer
CategoryDiagnostic Instruments
Description

Automatic chemiluminescence immunoassay analyzer for medium-throughput laboratories, compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.

7Shine i2000 Fully Automatic Chemiluminescence Immunoassay Analyzer
CategoryDiagnostic Instruments
Description

Compact, high-capacity chemiluminescence immunoassay analyzer compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.

8Shine i1000 Fully Automatic Chemiluminescence Immunoassay Analyzer
CategoryDiagnostic Instruments
Description

Smallest fully automatic chemiluminescence immunoassay analyzer in the Shine lineup, compatible with AE, AP, and HRP chemiluminescence protocols.

9Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System
CategoryDiagnostic Instruments
Description

High-throughput clinical chemistry and immunoassay analyzer delivering complete workflow automation in a space-saving 5 m² footprint for mid- and high-volume laboratories.

10Ideal 30 Fully Automatic Molecular Diagnostic System
CategoryDiagnostic Instruments
Description

Fully automatic molecular diagnostic system for human diagnostics combining magnetic bead-based nucleic acid extraction with quantitative fluorescence PCR (qPCR) for rapid results.

11Nous 30V Fully Automatic Molecular Diagnostic System for Veterinary Diagnostics
CategoryDiagnostic Instruments
Description

Fully automatic molecular diagnostic system specifically designed for veterinary diagnostics applications.

12WS-Mi6000 Multi-Channel Immunofluorescence Analyzer
CategoryDiagnostic Instruments
Description

Multi-channel fluorescent lateral flow reader designed for labs and departments in hospitals.

13WS-Si1500 Hand-Held Immunofluorescence Analyzer
CategoryDiagnostic Instruments
Description

Hand-held immunofluorescence analyzer for point-of-care testing applications.

14WS-Si1000 Single-Channel Immunofluorescence Analyzer
CategoryDiagnostic Instruments
Description

Single-channel immunofluorescence analyzer for point-of-care testing applications.

15FAtraction32 Nucleic Acid Extraction System
CategoryDiagnostic Instruments
Description

Nucleic acid extraction system using magnetic bead separation technology for molecular diagnostics sample preparation.

16FAlight16 Rapid Real-time Fluorescent Quantitative PCR System
CategoryDiagnostic Instruments
Description

Rapid real-time fluorescent quantitative PCR system using innovative liquid circulation refrigeration combined with unique Peltier temperature control technology.

17NGS Reagent Services
CategoryIVD Reagent Services
Description

Next-generation sequencing reagent services for women's health, men's health, children's health, reproductive health, pharmacogenetic testing, chronic diseases, cancers, and microbiome applications.

18FP MAP Protein-Free Blocker
CategoryIVD Raw Materials
Description

Protein-free blocking agent used in diagnostic immunoassay applications to reduce background noise and improve assay specificity.

19Mpox Antigen Diagnostic Solutions
CategoryIVD Reagents / Raw Materials
Description

Diagnostic solutions for mpox (monkeypox) antigen detection, including raw materials and reagents for IVD manufacturers.

20HIV-P24 Raw Material for Early HIV Detection
CategoryIVD Raw Materials
Description

Fourth-generation HIV detection raw material targeting HIV-1/HIV-2 antibodies and P24 antigen. Reduces the detection window period to 2-3 weeks, detects major global HIV subtypes and circulating recombinant forms, with overall specificity exceeding 99.8%.

21TeloScript Reverse Transcriptase
CategoryIVD Raw Materials
Description

Reverse transcriptase enzyme for molecular diagnostics applications including cDNA synthesis and RT-qPCR workflows.

22AK Taq DNA Polymerase V2
CategoryIVD Raw Materials
Description

Taq DNA polymerase enzyme used in PCR applications for molecular diagnostics.

23Alzheimer's Disease Blood Testing Solutions
CategoryIVD Raw Materials
Description

Complete set of raw materials and bulk reagents for Alzheimer's disease blood testing, covering core biomarkers p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. Demonstrates high sensitivity, specificity, and correlation to predicate kits.

24Pf-pLDH Malaria Raw Materials
CategoryIVD Raw Materials
Description

High-performance Plasmodium falciparum pLDH raw materials for malaria diagnosis with 10x higher sensitivity than conventional solutions; detection limit as low as 0.4 ng/mL, validated against NIBSC reference materials and CDC panels. No cross-reactivity with Pv-PLDH or Pf-HRPII.

25LAMP Solutions for Rapid Molecular Diagnostics
CategoryIVD Raw Materials
Description

Loop-mediated isothermal amplification (LAMP) raw material solutions for rapid molecular diagnostics workflows.

26High-Sensitivity cTnI Antibody Pairs (hs-cTnI)
CategoryIVD Raw Materials
Description

High-sensitivity cardiac troponin I (hs-cTnI) antibody pairs using chimeric (human-mouse), rabbit, sheep, and goat antibodies, achieving femtogram-scale sensitivity. R² 0.9928 in AE-based CLIA and 0.9902 in ALP-based CLIA within linear ranges.

27Total Vitamin D Double Reagent Solution for Whole Blood
CategoryIVD Reagents
Description

Double-reagent solution for quantitative detection of Vitamin D in human whole blood using latex immunoturbidimetry and the double antibody method. Correlation R² > 0.96 vs competitor turbidimetric reagent across 142 clinical samples.

28Double Antibody VD Reagent Solution (Biochemistry Platform)
CategoryIVD Reagents
Description

Liquid dual-reagent Vitamin D biochemistry platform product with double-antibody method, suitable for all brands of automatic biochemical analyzers.

29Chemiluminescence One-Stop Solution
CategoryDiagnostic Solutions / Bundles
Description

Comprehensive chemiluminescence solution bundling high-performance core raw materials, over 70 self-developed assays, and the Shine i-Series CLIA analyzers (i1000–i8000/9000, mT8000) for IVD manufacturers.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-08
Description

PT Fapon and PT Bio Farma (Indonesia's state-owned pharmaceutical holding company) forged a strategic partnership to advance IVD localization and innovation in Indonesia. Bio Farma is a state-owned pharmaceutical holding company with extensive manufacturing and distribution infrastructure in Indonesia.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-13
Description

Fapon and PT Kalbe Farma (one of Southeast Asia's largest public pharmaceutical companies, established 1966) signed a Memorandum of Understanding (MoU) at MEDICA 2023 to deepen cooperation and boost Indonesia's IVD development. This builds on Fapon's existing partnerships in Indonesia and aims to accelerate local IVD manufacturing and market penetration.

3China Innovation Center (C.I.C.) at Dubai Chambers
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2023-11-02
Description

Fapon signed a Memorandum of Cooperation (MoC) with China Innovation Center at Dubai Chambers during the Dubai Business Forum 2023. The partnership aims to cultivate strategic partnerships in IVD, pharmaceuticals, therapeutics, biomarker screening, and healthcare-related investments to boost Dubai's healthcare industry. C.I.C. serves as a platform for Chinese tech companies to connect with GCC region clients.

en.faponbiotech.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-10-12
Description

Fapon signed a strategic cooperation agreement with Halodoc, Indonesia's largest telehealth platform. The partnership establishes a joint venture to grow the IVD business and deliver high-quality diagnostic products in Indonesia. Fapon provides raw materials, reagent solutions, and open-instrument platforms; Halodoc leverages its sales channels, academia, and industry connections for market expansion.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-10-01
Description

Prior to the formal joint venture announced in October 2023, Fapon and Halodoc had already established an initial partnership in October 2023 to drive the development of Indonesia's in-vitro diagnostics industry. This initial partnership preceded the formal joint venture structure.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-01
Description

Fapon became an industry member of the Stanford University Healthcare Innovation Lab (HIL) Affiliates Program, led by Dr. Michael Snyder. This membership provides cutting-edge scientific insights and opportunities in precision medicine, including access to research in infectious disease, diabetes, cancer, cardiovascular disease, AI/ML, and multi-omics data. Fapon was also invited to join the Mental Healthcare Innovations Summit.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-11-05
Description

Fapon Biotech entered a strategic partnership with Roche Diagnostics China at the 5th China International Import Expo (CIIE). The partnership encompasses close cooperation in raw material products and services, and molecular diagnostics. Both companies pool resources and combine strengths to jointly develop and improve one-stop solutions to meet local needs, accelerating R&D and translation of research results in the China IVD industry.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Fapon entered an exclusive license agreement with two Swiss biotech companies LASCCO SA and Abionic SA to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. Fapon has rights to research, develop, manufacture, and commercialize PSP raw materials and CLIA-based reagent solutions within China. PSP immunoassay holds CE mark, Australian registration, and expected FDA 510(k) clearance.

9Halo Bio / Orna Therapeutics
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Fapon Group collaborates with Dr. Alex Wesselhoeft (founder of Halo Bio and co-founder of Orna Therapeutics) to develop state-of-the-art circular RNA technology platforms, including circRNA design and engineering platform, novel delivery systems, and innovative vaccines. This partnership addresses bottlenecks in circRNA industrialization.

en.faponbiotech.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

KingMed Diagnostics operates the largest independent clinical laboratory network in China and increasingly develops proprietary IVD reagents and instruments, partially overlapping with Fapon's reagent services and clinical lab customer segment.

TypeBroad incumbent
Description

Bio-Rad Laboratories is a global life sciences incumbent with IVD and research reagent businesses spanning quality controls, immunoassays, and digital PCR — a broad incumbent that competes with Fapon's molecular diagnostics and clinical chemistry reagent offerings.

TypeBroad incumbent
Description

DiaSorin is a global IVD incumbent specializing in immunodiagnostics and molecular diagnostics with the LIAISON CLIA platform — a broad incumbent with comparable specialty assay focus to Fapon's CLIA reagents and open-instrument approach.

TypeDirect peer
Description

Beijing Strong Biotechnologies develops IVD diagnostic reagents, instruments, and raw materials in China, with a focus on chemiluminescence immunoassays and clinical chemistry — directly overlapping with Fapon's CLIA and clinical chemistry raw materials business.

TypeBroad incumbent
Description

Roche Diagnostics is the global IVD leader with the cobas closed-system platform spanning immunoassays, clinical chemistry, and molecular diagnostics. As Fapon's strategic partner in China and a global competitor, Roche represents both customer and competitive benchmark.

TypeDirect peer
Description

Autobio Diagnostics is one of China's largest listed IVD companies, producing immunoassay analyzers, reagents, and microbial diagnostics — a directly comparable vertically integrated Chinese IVD peer with similar global ambitions.

TypeBroad incumbent
Description

Mindray is a global Chinese medical device and IVD incumbent with broad CLIA, hematology, and ultrasound offerings, plus an international distribution network spanning 190+ countries — a much larger broad incumbent competing with Fapon's instruments and reagent services globally.

TypeEmerging player
Description

AllTest Biotech is a Chinese IVD company specializing in rapid diagnostic tests, infectious disease diagnostics, and lateral flow assays — an emerging player with partial overlap to Fapon's rapid test raw materials and reagent services.

TypeDirect peer
Description

Hybiome is a Chinese IVD raw materials and reagent manufacturer focused on chemiluminescence immunoassays, with a product portfolio spanning antigens, antibodies, and diagnostic instruments — directly comparable to Fapon's IVD raw materials and CLIA reagent offering.

10Shenzhen New Industries Biomedical (Snibe)
TypeDirect peer
Description

Snibe is a leading Chinese IVD company manufacturing CLIA analyzers (MAGLUMI series) and reagents for clinical diagnostics. It competes with Fapon's Shine i-Series chemiluminescence instruments and reagent services in both domestic and overseas markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fapon

In Vitro Diagnostics (IVD) Raw Materials and Instrumentsen.faponbiotech.com

Fapon Biotech is a Chinese IVD company founded in 2001 that provides a vertically integrated one-stop solution spanning raw materials, reagent services, and open-system instruments, serving 2,500+ IVD manufacturers and laboratories across 70+ countries through direct sales and channel partnerships.

What Fapon does

Fapon Biotech is a privately held Chinese in vitro diagnostics (IVD) company founded in 2001 and headquartered in Dongguan, Guangdong. The company operates a vertically integrated 'one-stop IVD total solution' model spanning three product lines: core raw materials (antigens, antibodies, diagnostic enzymes, blockers, and calibrators), customized reagent development services, and open-system instruments (notably the Shine i-Series CLIA analyzers, the Ideal 30 molecular diagnostic system, and immunofluorescence analyzers). Technology coverage spans chemiluminescence immunoassay, ELISA, rapid test, molecular diagnostics (qPCR, NGS, LAMP), and clinical chemistry. The company serves IVD reagent manufacturers, clinical laboratories, and emerging-market IVD companies across 70+ countries via 2,500+ partners, using direct field sales, industry trade shows, and channel partnerships including joint ventures in Indonesia.

Fapon generates revenue through three streams: IVD raw materials sales to global IVD manufacturers as the primary revenue base, customized reagent services for assay development, and open-system instrument sales. Its economic model is built on an ecosystem approach — placing open-architecture analyzers (5,000+ globally) that allow partners to develop proprietary reagents, creating switching costs and recurring consumables demand. The company has supplied raw materials for 10+ billion COVID-19 tests and 200+ million malaria tests annually, supporting scale-based cost advantages. Pricing is negotiated on a B2B basis with multi-year contracts; no public pricing is disclosed.

The business is anchored by 1,200+ patent applications (450+ granted), 40% R&D headcount, and emerging scientific partnerships including Stanford Healthcare Innovation Lab and circRNA platform collaborations. The company operates a US R&D subsidiary in Lexington, MA (opened November 2023), and has pursued strategic partnerships with Roche Diagnostics China, Halodoc, Kalbe Farma, and Bio Farma to expand into new geographies. AI is used in biomarker discovery and bio-molecule design, though it functions as an internal R&D accelerator rather than a customer-facing product.

Fapon firmographics

Firmographics
Name
Fapon
Legal name
Fapon Biotech Inc.
Website
https://en.faponbiotech.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
101–250 employees
Short description
Fapon Biotech is a Chinese IVD company founded in 2001 that provides a vertically integrated one-stop solution spanning raw materials, reagent services, and open-system instruments, serving 2,500+ IVD manufacturers and laboratories across 70+ countries through direct sales and channel partnerships.
Ownership category
akta.pro rank

Fapon industry classification

Industry
Product category
In Vitro Diagnostics (IVD) Raw Materials and Instruments
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • IVD raw materials
  • Chemiluminescence immunoassay
  • Molecular diagnostics
  • Diagnostic reagent services
  • Open-system analyzers

Where Fapon is headquartered

Location

Headquarters

HQ city
Dongguan
HQ country
China
HQ region
Asia

Offices5 records

Markets served

Fapon business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. IVD Raw Materials Sales: Sale of core IVD raw materials including antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers, and calibrators for CLIA, ELISA, rapid test, clinical chemistry, and molecular diagnostics platforms. This is Fapon's primary revenue stream, serving as a fundamental upstream supplier to IVD reagent manufacturers worldwide.
  2. IVD Reagent Services: Customized reagent development and manufacturing services for CLIA, high-throughput sequencing, quantitative fluorescence PCR (qPCR), and fluorescence-based lateral flow immunoassay. Provides semi-finished and finished bulk reagent solutions to IVD manufacturers.
  3. Open-System Instruments: Sale of open-architecture diagnostic instruments including the Shine i-Series chemiluminescence analyzers (i1000, i2000, i3000, i6000, i8000/9000, mT8000), Ideal 30 molecular diagnostic system, WS-Mi immunofluorescence analyzers, and Nous 30V veterinary analyzer. Instruments are sold to IVD manufacturers and laboratories.
  4. Licensing (PSP Biomarker): Exclusive license from LASCCO SA and Abionic SA to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. Fapon develops, manufactures, and commercializes PSP raw materials and CLIA-based reagent solutions, generating revenue through product sales in the licensed territory.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B raw materials and reagent services — pricing not publicly disclosed

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Fapon product offering

Product offering

Core offering

Fapon Biotech is a global IVD upstream supplier providing a vertically integrated one-stop solution comprising (1) core raw materials — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators for CLIA, ELISA, rapid test, clinical chemistry and molecular diagnostics; (2) customized reagent development services for CLIA, NGS, qPCR and fluorescence lateral flow assays; and (3) open-system diagnostic instruments including the Shine i-Series chemiluminescence analyzers, Ideal/Nous molecular diagnostic systems, and WS-series immunofluorescence analyzers. The portfolio serves IVD reagent manufacturers, clinical laboratories, and emerging-market diagnostics companies across 70+ countries.

Product overview

Fapon is a leading global provider of IVD total solutions comprising three interconnected product lines: IVD raw materials (antigens, antibodies, diagnostic enzymes, and blockers), IVD reagent services (customized development for CLIA, NGS, qPCR, and fluorescence-based assays), and open-system instruments (Shine i-series chemiluminescence analyzers ranging from i1000 to mT8000, Ideal and Nous molecular diagnostic systems, and WS immunofluorescence analyzers). The company also offers specialized reagent solutions for specific disease areas including infectious diseases (HIV, malaria, mpox), cardiac markers (hs-cTnI), Alzheimer's disease biomarkers, and vitamin D testing. The portfolio is unified through an ecosystem approach where raw materials feed into reagent services which run on open instruments, enabling partners to develop complete diagnostic solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • IVD Raw Materials Core raw materials for in vitro diagnostics — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators — supplied to IVD reagent manufacturers across CLIA, ELISA, rapid test, clinical chemistry, and molecular diagnostics platforms. Over 1,300 product offerings across the line.
  • IVD Reagent Services Customized reagent development and manufacturing services for CLIA, high-throughput sequencing (NGS), quantitative fluorescence PCR (qPCR), and fluorescence-based lateral flow immunoassay (FIA) applications. Delivers semi-finished and finished bulk reagent solutions to IVD manufacturers.
  • Open-System Diagnostic Instruments Open instrument platforms — chemiluminescence, molecular POCT, fluorescence immunochromatography, and high-throughput gene sequencing analyzers — sold to IVD manufacturers and laboratories. Enables partners to develop and run proprietary reagents on Fapon analyzers.
  • Shine i8000/9000 Fully Automatic Chemiluminescence Immunoassay Analyzer High-speed fully automatic chemiluminescence immunoassay analyzer with detection speed of 900 tests/hour, designed for mid- and high-volume laboratories. Compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
  • Shine i6000 Fully Automatic Chemiluminescence Immunoassay Analyzer Automatic chemiluminescence immunoassay analyzer designed for medium-throughput laboratories, compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
  • Shine i3000 Fully Automatic Chemiluminescence Immunoassay Analyzer Automatic chemiluminescence immunoassay analyzer for medium-throughput laboratories, compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
  • Shine i2000 Fully Automatic Chemiluminescence Immunoassay Analyzer Compact, high-capacity chemiluminescence immunoassay analyzer compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
  • Shine i1000 Fully Automatic Chemiluminescence Immunoassay Analyzer Smallest fully automatic chemiluminescence immunoassay analyzer in the Shine lineup, compatible with AE, AP, and HRP chemiluminescence protocols.
  • Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System High-throughput clinical chemistry and immunoassay analyzer delivering complete workflow automation in a space-saving 5 m² footprint for mid- and high-volume laboratories.
  • Ideal 30 Fully Automatic Molecular Diagnostic System Fully automatic molecular diagnostic system for human diagnostics combining magnetic bead-based nucleic acid extraction with quantitative fluorescence PCR (qPCR) for rapid results.
  • Nous 30V Fully Automatic Molecular Diagnostic System for Veterinary Diagnostics Fully automatic molecular diagnostic system specifically designed for veterinary diagnostics applications.
  • WS-Mi6000 Multi-Channel Immunofluorescence Analyzer Multi-channel fluorescent lateral flow reader designed for labs and departments in hospitals.
  • WS-Si1500 Hand-Held Immunofluorescence Analyzer Hand-held immunofluorescence analyzer for point-of-care testing applications.
  • WS-Si1000 Single-Channel Immunofluorescence Analyzer Single-channel immunofluorescence analyzer for point-of-care testing applications.
  • FAtraction32 Nucleic Acid Extraction System Nucleic acid extraction system using magnetic bead separation technology for molecular diagnostics sample preparation.
  • FAlight16 Rapid Real-time Fluorescent Quantitative PCR System Rapid real-time fluorescent quantitative PCR system using innovative liquid circulation refrigeration combined with unique Peltier temperature control technology.
  • NGS Reagent Services Next-generation sequencing reagent services for women's health, men's health, children's health, reproductive health, pharmacogenetic testing, chronic diseases, cancers, and microbiome applications.
  • FP MAP Protein-Free Blocker Protein-free blocking agent used in diagnostic immunoassay applications to reduce background noise and improve assay specificity.
  • Mpox Antigen Diagnostic Solutions Diagnostic solutions for mpox (monkeypox) antigen detection, including raw materials and reagents for IVD manufacturers.
  • HIV-P24 Raw Material for Early HIV Detection Fourth-generation HIV detection raw material targeting HIV-1/HIV-2 antibodies and P24 antigen. Reduces the detection window period to 2-3 weeks, detects major global HIV subtypes and circulating recombinant forms, with overall specificity exceeding 99.8%.
  • TeloScript Reverse Transcriptase Reverse transcriptase enzyme for molecular diagnostics applications including cDNA synthesis and RT-qPCR workflows.
  • AK Taq DNA Polymerase V2 Taq DNA polymerase enzyme used in PCR applications for molecular diagnostics.
  • Alzheimer's Disease Blood Testing Solutions Complete set of raw materials and bulk reagents for Alzheimer's disease blood testing, covering core biomarkers p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. Demonstrates high sensitivity, specificity, and correlation to predicate kits.
  • Pf-pLDH Malaria Raw Materials High-performance Plasmodium falciparum pLDH raw materials for malaria diagnosis with 10x higher sensitivity than conventional solutions; detection limit as low as 0.4 ng/mL, validated against NIBSC reference materials and CDC panels. No cross-reactivity with Pv-PLDH or Pf-HRPII.
  • LAMP Solutions for Rapid Molecular Diagnostics Loop-mediated isothermal amplification (LAMP) raw material solutions for rapid molecular diagnostics workflows.
  • High-Sensitivity cTnI Antibody Pairs (hs-cTnI) High-sensitivity cardiac troponin I (hs-cTnI) antibody pairs using chimeric (human-mouse), rabbit, sheep, and goat antibodies, achieving femtogram-scale sensitivity. R² 0.9928 in AE-based CLIA and 0.9902 in ALP-based CLIA within linear ranges.
  • Total Vitamin D Double Reagent Solution for Whole Blood Double-reagent solution for quantitative detection of Vitamin D in human whole blood using latex immunoturbidimetry and the double antibody method. Correlation R² > 0.96 vs competitor turbidimetric reagent across 142 clinical samples.
  • Double Antibody VD Reagent Solution (Biochemistry Platform) Liquid dual-reagent Vitamin D biochemistry platform product with double-antibody method, suitable for all brands of automatic biochemical analyzers.
  • Chemiluminescence One-Stop Solution Comprehensive chemiluminescence solution bundling high-performance core raw materials, over 70 self-developed assays, and the Shine i-Series CLIA analyzers (i1000–i8000/9000, mT8000) for IVD manufacturers.

Quantifiable outcome

  • hs-cTnI assay correlation (R²) reaches 0.9928 in AE-based CLIA within linear range (297 samples) and 0.9362 at concentrations < 0.1 ng/mL (141 samples)
  • +9 more outcomes

Companies that use Fapon

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Fapon technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature12 records

Fapon partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core.

  • PT Bio FarmacoreStrategic or Co-development Partner · 8 December 2024PT Fapon and PT Bio Farma (Indonesia's state-owned pharmaceutical holding company) forged a strategic partnership to advance IVD localization and innovation in Indonesia. Bio Farma is a state-owned pharmaceutical holding company with extensive manufacturing and distribution infrastructure in Indonesia.
  • PT Kalbe Farma TbkcoreChannel Partner/ Reseller/ Distributor · 13 November 2023Fapon and PT Kalbe Farma (one of Southeast Asia's largest public pharmaceutical companies, established 1966) signed a Memorandum of Understanding (MoU) at MEDICA 2023 to deepen cooperation and boost Indonesia's IVD development. This builds on Fapon's existing partnerships in Indonesia and aims to accelerate local IVD manufacturing and market penetration.
  • China Innovation Center (C.I.C.) at Dubai ChamberscoreGTM or Marketing Partner · 2 November 2023Fapon signed a Memorandum of Cooperation (MoC) with China Innovation Center at Dubai Chambers during the Dubai Business Forum 2023. The partnership aims to cultivate strategic partnerships in IVD, pharmaceuticals, therapeutics, biomarker screening, and healthcare-related investments to boost Dubai's healthcare industry. C.I.C. serves as a platform for Chinese tech companies to connect with GCC region clients.
  • HalodoccoreChannel Partner/ Reseller/ Distributor · 12 October 2023Fapon signed a strategic cooperation agreement with Halodoc, Indonesia's largest telehealth platform. The partnership establishes a joint venture to grow the IVD business and deliver high-quality diagnostic products in Indonesia. Fapon provides raw materials, reagent solutions, and open-instrument platforms; Halodoc leverages its sales channels, academia, and industry connections for market expansion.
  • HalodoccoreChannel Partner/ Reseller/ Distributor · 1 October 2023Prior to the formal joint venture announced in October 2023, Fapon and Halodoc had already established an initial partnership in October 2023 to drive the development of Indonesia's in-vitro diagnostics industry. This initial partnership preceded the formal joint venture structure.
  • Stanford University Healthcare Innovation LabcoreStrategic or Co-development Partner · 1 July 2023Fapon became an industry member of the Stanford University Healthcare Innovation Lab (HIL) Affiliates Program, led by Dr. Michael Snyder. This membership provides cutting-edge scientific insights and opportunities in precision medicine, including access to research in infectious disease, diabetes, cancer, cardiovascular disease, AI/ML, and multi-omics data. Fapon was also invited to join the Mental Healthcare Innovations Summit.
  • Roche Diagnostics ChinacoreStrategic or Co-development Partner · 5 November 2022Fapon Biotech entered a strategic partnership with Roche Diagnostics China at the 5th China International Import Expo (CIIE). The partnership encompasses close cooperation in raw material products and services, and molecular diagnostics. Both companies pool resources and combine strengths to jointly develop and improve one-stop solutions to meet local needs, accelerating R&D and translation of research results in the China IVD industry.
  • LASCCO SA and Abionic SAcoreOEM/ Whitelabel/ Licensing PartnerFapon entered an exclusive license agreement with two Swiss biotech companies LASCCO SA and Abionic SA to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. Fapon has rights to research, develop, manufacture, and commercialize PSP raw materials and CLIA-based reagent solutions within China. PSP immunoassay holds CE mark, Australian registration, and expected FDA 510(k) clearance.
  • Halo Bio / Orna TherapeuticscoreStrategic or Co-development PartnerFapon Group collaborates with Dr. Alex Wesselhoeft (founder of Halo Bio and co-founder of Orna Therapeutics) to develop state-of-the-art circular RNA technology platforms, including circRNA design and engineering platform, novel delivery systems, and innovative vaccines. This partnership addresses bottlenecks in circRNA industrialization.

Scale indicators13 records

Recent moves7 records

Expansion highlights5 records

Fapon competitors and assessment

Company assessment

Emerging players

  • KingMed Diagnostics: KingMed Diagnostics operates the largest independent clinical laboratory network in China and increasingly develops proprietary IVD reagents and instruments, partially overlapping with Fapon's reagent services and clinical lab customer segment.
  • Hangzhou AllTest Biotech: AllTest Biotech is a Chinese IVD company specializing in rapid diagnostic tests, infectious disease diagnostics, and lateral flow assays — an emerging player with partial overlap to Fapon's rapid test raw materials and reagent services.

Broad incumbents

  • Bio-Rad Laboratories: Bio-Rad Laboratories is a global life sciences incumbent with IVD and research reagent businesses spanning quality controls, immunoassays, and digital PCR — a broad incumbent that competes with Fapon's molecular diagnostics and clinical chemistry reagent offerings.
  • DiaSorin: DiaSorin is a global IVD incumbent specializing in immunodiagnostics and molecular diagnostics with the LIAISON CLIA platform — a broad incumbent with comparable specialty assay focus to Fapon's CLIA reagents and open-instrument approach.
  • Roche Diagnostics: Roche Diagnostics is the global IVD leader with the cobas closed-system platform spanning immunoassays, clinical chemistry, and molecular diagnostics. As Fapon's strategic partner in China and a global competitor, Roche represents both customer and competitive benchmark.
  • Mindray: Mindray is a global Chinese medical device and IVD incumbent with broad CLIA, hematology, and ultrasound offerings, plus an international distribution network spanning 190+ countries — a much larger broad incumbent competing with Fapon's instruments and reagent services globally.

Direct peers

  • Beijing Strong Biotechnologies: Beijing Strong Biotechnologies develops IVD diagnostic reagents, instruments, and raw materials in China, with a focus on chemiluminescence immunoassays and clinical chemistry — directly overlapping with Fapon's CLIA and clinical chemistry raw materials business.
  • Autobio Diagnostics: Autobio Diagnostics is one of China's largest listed IVD companies, producing immunoassay analyzers, reagents, and microbial diagnostics — a directly comparable vertically integrated Chinese IVD peer with similar global ambitions.
  • Hybiome: Hybiome is a Chinese IVD raw materials and reagent manufacturer focused on chemiluminescence immunoassays, with a product portfolio spanning antigens, antibodies, and diagnostic instruments — directly comparable to Fapon's IVD raw materials and CLIA reagent offering.
  • Shenzhen New Industries Biomedical (Snibe): Snibe is a leading Chinese IVD company manufacturing CLIA analyzers (MAGLUMI series) and reagents for clinical diagnostics. It competes with Fapon's Shine i-Series chemiluminescence instruments and reagent services in both domestic and overseas markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Fapon social profiles

Digital presence

Fapon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fapon leadership team

Management profile

Number of profiles

Profiles6 records

Fapon subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Fapon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fapon M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fapon

What does Fapon do?

Fapon Biotech is a global IVD upstream supplier providing a vertically integrated one-stop solution comprising (1) core raw materials — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators for CLIA, ELISA, rapid test, clinical chemistry and molecular diagnostics; (2) customized reagent development services for CLIA, NGS, qPCR and fluorescence lateral flow assays; and (3) open-system diagnostic instruments including the Shine i-Series chemiluminescence analyzers, Ideal/Nous molecular diagnostic systems, and WS-series immunofluorescence analyzers. The portfolio serves IVD reagent manufacturers, clinical laboratories, and emerging-market diagnostics companies across 70+ countries.

Is Fapon a public or private company?

Fapon is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Fapon founded?

Fapon was founded in 2001. It employs 101 to 250 people.

Where is Fapon based?

Fapon is headquartered in Dongguan, China, in the Asia region.

How does Fapon make money?

Four revenue lines are on record. IVD Raw Materials Sales are the primary driver. The others are IVD Reagent Services, open-System Instruments and licensing (PSP Biomarker).

Who are Fapon's main competitors?

Emerging players on record are KingMed Diagnostics and Hangzhou AllTest Biotech. Broad incumbents are Bio-Rad Laboratories, DiaSorin, Roche Diagnostics and Mindray. Direct peers are Beijing Strong Biotechnologies, Autobio Diagnostics, Hybiome and Shenzhen New Industries Biomedical (Snibe).

Does Fapon have an API?

No public API is recorded for Fapon.

What industry is Fapon in?

Fapon's product category is In Vitro Diagnostics (IVD) Raw Materials and Instruments. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 325413 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTechnology-Driven, Global Footprint: Fapon Spotlights Localization-Focused One-Stop IVD Solutions at WHX Labs Dubai 2026Fapon, a global life sciences company, is showcasing its comprehensive one-stop IVD solutions at WHX Labs Dubai 2026 from February 10–13 at the Dubai World Trade Centre. The company is highlighting its Local Manufacturing Solutions covering chemiluminescence immunoassay, clinical biochemistry, lateral flow assay, and molecular diagnostics platforms, alongside an advanced Alzheimer's Disease blood testing solution supplying raw materials for key biomarkers including p-tau 217, p-tau 181, Aβ40, Aβ42, GFAP, and NfL. Fapon provides end-to-end localization support to partners globally, with facilities spanning over 100,000 m², serving over 70 countries and partnering with more than 2,500 organizations worldwide.PR NewswireFapon auf der MEDICA 2025: KI-gesteuerte Durchbrüche bei Diagnoselösungen, darunter fortschrittliche AD-BluttestsFapon, a global life science company, is exhibiting at MEDICA 2025 in Düsseldorf from November 17–20, 2025, presenting its AI-driven diagnostic R&D model and a portfolio of advanced Alzheimer's Disease (AD) blood test solutions featuring biomarkers such as p-tau 217, p-tau 181, and Amyloid-beta 40/42. The company is also showcasing its One-Stop-IVD solutions including the automated Shine mT8000 chemiluminescence system and over 70 self-developed assay panels, serving IVD manufacturers with raw materials, reagents, and open-system instruments. Fapon's products and services are currently available in over 70 countries and regions through more than 2,500 global partners.PR NewswireFapon at MEDICA 2025: AI-Driven Breakthroughs in Diagnostic Solutions, Featuring Advanced AD Blood TestingFapon, a global life sciences organization, is exhibiting at MEDICA 2025 in Düsseldorf, Germany from November 17–20, showcasing its AI-driven diagnostic R&D capabilities and Alzheimer's disease blood testing solutions for IVD manufacturers. The company offers a complete set of raw materials and bulk reagents covering core AD biomarkers including p-tau 217, p-tau 181, amyloid beta 40/42, GFAP, NfL, and APOE4, along with one-stop IVD solutions including over 70 self-developed assays and open-system chemiluminescence analyzers. Fapon's products and services reach over 70 countries and regions with more than 2,500 partners worldwide, with the company aiming to advance global healthcare through technology transfer and localized manufacturing support.Mpo-magFapon Features AI-Driven Breakthroughs in Diagnostic SolutionsFapon showcased its AI-driven diagnostic solutions and Alzheimer's disease blood testing products at Medica in Düsseldorf, Germany. The company highlighted its biomarker discovery model, high-sensitivity raw materials, and automated systems for clinical diagnostics, which are supplied to over 70 countries.PR NewswireFapon to Debut Shine mT8000 Open-Access, High Throughput Clinical Chemistry and Immunoassay Analyzer at ADLM 2025Fapon is set to debut its Shine mT8000 Fully Automated Clinical Chemistry and Immunoassay System at the ADLM 2025 Annual Scientific Meeting in Chicago. The new platform offers a throughput of up to 2,400 tests per hour for biochemistry and features AI-powered software to streamline laboratory workflows. This launch expands Fapon's portfolio of diagnostic solutions, which currently include over 8,000 units deployed globally.PR NewswireNaliehavá potreba včasnej detekcie mukoremykózy počas COVID-19Mucormycosis (black fungus) cases have surged globally during the COVID-19 pandemic, with India reporting over 57,150 cases and a 54% mortality rate, while additional cases have been documented in Pakistan, Russia, Nepal, Chile, Brazil, and other countries facing high diabetes prevalence and COVID-19 outbreaks. Fapon Biotech, a China-headquartered in vitro diagnostics reagent supplier with over 1,000 IVD partners worldwide and more than 10 years of operations in India, has issued a public call for cooperation with academic and industry partners to jointly develop mucormycosis diagnostic tests. The company is offering its technology platforms — including colloidal gold, immunofluorescence, ELISA, CLIA, latex-enhanced immunoturbidimetry, and PCR — as well as OEM and contract manufacturing services to accelerate product development and market entry.PR NewswireLa urgente necesidad de la detección temprana de la mucormicosis durante la pandemia de COVID-19Fapon Biotech is calling for academic and industry cooperation to develop early diagnostic tests for mucormycosis, a fungal infection causing high mortality in India and other countries during the COVID-19 pandemic. The company aims to leverage its experience in IVD reagent supply to accelerate diagnosis and mitigate the health crisis associated with late detection.PR NewswireNaléhavá potřeba včasné detekce mukoremykózy během COVID-19Mukormykóza, a severe infection referred to as black fungus, has seen over 57,150 cases in India during the COVID-19 pandemic, with a mortality rate of 54%. Fapon Biotech Inc is calling for collaboration with academic and industry partners to develop diagnostic tests for early detection of this infection, emphasizing the urgency due to its late diagnosis and worsening health burden amid the pandemic. The company has over 1,000 global IVD partners and aims to enhance diagnostic capabilities through shared development platforms.PR NewswireThe Pressing Need for Early Detection of Mucormycosis during COVID-19Fapon Biotech is calling for cooperation with academic and industry partners to develop diagnostic tests for mucormycosis (black fungus), a devastating infection that has surged in India during COVID-19 with over 57,150 cases and 54% mortality. The company is offering its upstream raw material development platforms and downstream reagent application platforms, including colloidal gold, immunofluorescence, ELISA, PCR, and other technologies, as well as OEM and contract manufacturing services. The company positions itself as a mainstream COVID-19 reagent raw material supplier with over 1,000 IVD partners worldwide and more than 10 years of business operations in India, seeking partnerships to help areas with overwhelmed healthcare burdens respond to the complication of mucormycosis.PR NewswireSegunda donación de Fapon para la COVID-19Fapon Biotech Inc. announced its second COVID-19 donation, providing 100 million anti-SARS-CoV-2 fully human RBD IgM and IgG quality control test materials to support reliable antibody testing. The donation builds on the company's first initiative in February, which supplied PCR test components to manufacturers in 40 countries, enabling production of over 100 million diagnostic tests. Fapon highlighted its expanded manufacturing capacity, reporting a 500% increase in production capability since the pandemic began.